Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model.
Clinical trial NCT06311916 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06311916
- Sponsor
- Chen Xiaoping
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2027-12-31
- Enrollment
- 312
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.